Abstract

The controversial question of how much disease is caused by medical intervention goes to the heart of a social movement within the profession of pharmacy. The fate of “clinical pharmacy” is tied to the ability of pharmacists to detect and correct errors in prescribed medications, a potential source of iatrogenic disease. The dilemma for pharmacists is that documentation of their clinical activities could increase the liability exposure of medical organizations and impugn the reputations of physicians as competent prescribers of drugs. A participant observation study reveals how problems of drug therapy and the work of clinical pharmacists are negotiated within hospital settings.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.